Vea MedIQ en Español
Dr. Carlos Rieder comenta neste vídeo sobre alguns trabalhos que foram apresentados na Reunião Anual do AAN 2022, destacando os trabalhos que abordaram as demências, em especial a doença de Alzheimer, tendo em vista que é a doença neurodegenerativa mais comum e prevalente na nossa população.
Reunião Anual do AAN: Highlights em doenças neurodegerativas
Escrito por: Zilda Machado Meneghelo em 3 de maio de 2022
1 min de leitura
Referências
Sharon Cohen, MD, et al., Item-Level Analysis of Clinical Measures in Patients With Early Symptomatic Alzheimer’s Disease Following Treatment With High-Dose Aducanumab in the Phase 3 EMERGE Study. Presented at 2022 AAN Annual Meeting.
Ahmed Chenna, PhD et al., Quantitation of Nervous System Proteins NF-L, t-Tau, p-Tau181, Aß1-42, Aß1-40, GFAP and Inflammatory Cytokines IL-6, IL-10, TNFa in Alzheimer’s Disease Plasma. Presented at 2022 AAN Annual Meeting.
Raumin Shawn Neuville et al., One Hundred Centenarians: Brain Pathology and Relationship to Dementia in The 90+ Study. Presented at 2022 AAN Annual Meeting.
Ramakrishna Nirogi, PhD et al., Masupirdine (SUVN-502), A Serotonin Receptor Sub-Type 6 Antagonist for the Potential Treatment of Agitation and Psychosis in Patients with Dementia of Alzheimer’s Type. Presented at 2022 AAN Annual Meeting.
